Cardinal Health Second Quarter 2025 Earnings: EPS Beats Expectations
Net income: US$400.0m (up 13% from 2Q 2024). Profit margin: 0.7% (up from 0.6% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: US$1.65 (up from US$1.44 in 2Q 2024).
Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is being recorded.
Cardinal Health Inc Q2 Profit Increases, Beats Estimates
Cardinal Health Inc (CAH) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The
Cardinal Health Inc (CAH) Q2 2025 Earnings Call Highlights: Strong Pharma Growth Amid Revenue ...
Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment performance and strategic acquisitions.
Cardinal: Fiscal Q2 Earnings Snapshot
The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.75 per share. The prescription drug distributor posted revenue of $55.26 billion in the period, also topping Street forecasts.
Cardinal (CAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cardinal Health (CAH) reported $55.26 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 3.8%. EPS of $1.93 for the same period compares to $1.82 a year ago.
Cardinal Health raises FY25 EPS guidance to $7.85-$8 amid specialty growth and acquisitions
Q2 2025 Management View CEO Jason Hollar emphasized strong Q2 performance driven by robust demand in Pharmaceutical and ...
Cardinal Health’s Strong Performance and Strategic Acquisitions Justify Buy Rating
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Modern Healthcare18h
Cardinal Health CEO Jason Hollar issues warning on tariffs
Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...
Citi raises Cardinal Health stock target to $130 on Pharma strength
Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous $129, while keeping a Neutral rating on the stock. The adjustment follows ...
Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Cardinal Health (NYSE:CAH – Get Free Report) had its target price hoisted by equities researchers at Wells Fargo & Company from $127.00 to $135.00 in a research note issued on Wednesday,Benzinga ...
Cardinal Health lifts 2025 profit forecast on specialty drugs demand
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.
Cardinal Health price target raised to $156 from $138 at Leerink
Leerink raised the firm’s price target on Cardinal Health (CAH) to $156 from $138 and keeps an Outperform rating on the shares. Q2 results ...
MDM18h
Cardinal Health 2Q Sales Rise 16% Outside of Optimum Impact
Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.
NBC4 Columbus2d
Dublin City Schools cancels plan to buy Cardinal Health building for $37 million
Dublin City Schools is withdrawing from an agreement to buy Cardinal Health’s headquarters for $37 million to serve as a high ...